J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak 

Slides:



Advertisements
Similar presentations
Date of download: 7/5/2016 From: Pathogenesis and Treatment of HIV-Associated Renal Diseases: Lessons from Clinical and Animal Studies, Molecular Pathologic.
Advertisements

A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa  T.M. Han, S. Naicker, P.K. Ramdial, A.G. Assounga 
Volume 88, Issue 5, Pages (November 2015)
Volume 80, Issue 7, Pages (October 2011)
Volume 81, Issue 11, Pages (June 2012)
Volume 65, Issue 2, Pages (February 2004)
An animal model of glomerular light-chain-associated amyloidogenesis depicts the crucial role of lysosomes  Jiamin Teng, Elba A Turbat-Herrera, Guillermo.
Persistent rejection of peritubular capillaries and tubules is associated with progressive interstitial fibrosis  Akira Shimizu, Kazuhiko Yamada, David.
Volume 65, Issue 5, Pages (May 2004)
Figure 1 Pathologic features of obesity-related glomerulopathy (ORG)
Paraneoplastic glomerulopathies: New insights into an old entity
Volume 72, Issue 10, Pages (November 2007)
Vivette D D'Agati, MD, Agnes B Fogo, MD, Jan A Bruijn, MD, J
Volume 58, Issue 1, Pages (July 2000)
Volume 67, Issue 5, Pages (May 2005)
Volume 76, Issue 5, Pages (September 2009)
Volume 68, Issue 3, Pages (September 2005)
Volume 85, Issue 6, Pages (June 2014)
Volume 68, Issue 6, Pages (December 2005)
Volume 69, Issue 10, Pages (May 2006)
Membranoproliferative Glomerulonephritis
Volume 54, Issue 6, Pages (January 1998)
Volume 85, Issue 2, Pages (January 2014)
Glomerular disease related to anti-VEGF therapy
Pdlim2 is a novel actin-regulating protein of podocyte foot processes
Hyperlipidemia aggravates renal disease in B6.ROP Os/+ mice
Patricia L. St. John, Dale R. Abrahamson  Kidney International 
Volume 78, Issue 2, Pages (July 2010)
Volume 59, Issue 1, Pages (January 2001)
Volume 77, Issue 11, Pages (June 2010)
Volume 87, Issue 2, Pages (February 2015)
A new mouse model of immune-mediated podocyte injury
Yang Wang, Yi Ping Wang, Yuet-Ching Tay, David C.H. Harris 
Volume 62, Issue 1, Pages (July 2002)
Volume 73, Issue 4, Pages (February 2008)
Wilhelm Kriz, Michel Lehir  Kidney International 
Volume 70, Issue 8, Pages (October 2006)
Volume 71, Issue 1, Pages (January 2007)
Volume 63, Issue 4, Pages (April 2003)
Lupus Nephritis: Proliferative Forms (WHO III, IV)
HIV-associated immune complex glomerulonephritis with “lupus-like” features: A clinicopathologic study of 14 cases1  Mark Haas, Sadhana Kaul, Joseph A.
Volume 57, Issue 1, Pages (January 2000)
Volume 70, Issue 7, Pages (October 2006)
Volume 54, Issue 2, Pages (August 1998)
Volume 83, Issue 6, Pages (June 2013)
M.B. Stokes, A.M. Valeri, G.S. Markowitz, V.D. D'Agati 
Volume 66, Issue 1, Pages (July 2004)
Volume 58, Issue 6, Pages (December 2000)
Nephrotic syndrome associated with hemophagocytic syndrome
S.H. Nasr, D.C. Preddie, G.S. Markowitz, G.B. Appel, V.D. D'Agati 
Glomerular injury is exacerbated in diabetic integrin α1-null mice
Volume 67, Issue 4, Pages (April 2005)
Volume 68, Issue 4, Pages (October 2005)
Prevention of mesangial sclerosis by bone marrow transplantation
Volume 74, Issue 2, Pages (July 2008)
Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene  C.K. Abrass, A.K. Berfield, M.C.
Obesity-related glomerulopathy: An emerging epidemic
Volume 72, Issue 3, Pages (August 2007)
Volume 63, Issue 1, Pages (January 2003)
B. Li, T. Morioka, M. Uchiyama, T. Oite  Kidney International 
A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa  T.M. Han, S. Naicker, P.K. Ramdial, A.G. Assounga 
Collapsing Glomerulopathy in Lambda Light Chain Amyloidosis: A Report of 2 Cases  Mazdak A. Khalighi, Alexander J. Gallan, Anthony Chang, Shane M. Meehan 
AJKD Atlas of Renal Pathology: Focal Segmental Glomerulosclerosis
Volume 85, Issue 1, Pages (January 2014)
Volume 73, Issue 9, Pages (May 2008)
Volume 70, Issue 2, Pages (July 2006)
Membranous and crescentic glomerulonephritis in a patient with anti-nuclear and anti- neutrophil cytoplasmic antibodies  A. Chang, O. Aneziokoro, S.M.
Volume 73, Issue 5, Pages (March 2008)
Volume 58, Issue 1, Pages (July 2000)
C1q nephropathy: A variant of focal segmental glomerulosclerosis
Presentation transcript:

Mice with altered α-actinin-4 expression have distinct morphologic patterns of glomerular disease  J.M. Henderson, S. al-Waheeb, A. Weins, S.V. Dandapani, M.R. Pollak  Kidney International  Volume 73, Issue 6, Pages 741-750 (March 2008) DOI: 10.1038/sj.ki.5002751 Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 1 Glomerular lesional involvement and distribution by morphologic pattern of injury in Actn4 transgenic mice. Data are categorized into juvenile (0–7 weeks), young adult (7–21 weeks), and old adult (>21 weeks) age groups. Genotypes indicated by WT (wild type), HET (heterozygous Actn4 K256E mutant), KI (homozygous Actn4 K256E mutant), and KO (homozygous Actn4 null). Height of bars and bar segments indicates mean percentage of glomeruli involved by lesions among all specimens examined within a specified genotype and age group combination. Shading indicates specific morphologic pattern of glomerular lesion. Number of specimens per age group-genotype combination (n) also indicated. Juvenile KI mice exhibited rare collapsing lesions involving 0.1% of glomeruli (data not shown in figure). Kidney International 2008 73, 741-750DOI: (10.1038/sj.ki.5002751) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 2 Kidney histology in juvenile and young adult Actn4 transgenic mice. Wild-type (WT) mice aged 6 weeks (a) and 14 weeks (b) showing normal kidney histology. Heterozygous Actn4 K256E mutant (KI) mice aged 4 weeks (c) exhibiting normal kidney histology and aged 14 weeks (d) showing focal glomerular hypertrophy (arrow). Homozygous Actn4 K256E mutant (KI) mice aged 4 weeks (e) showing focal glomerular hypertrophy and aged 14 weeks (f) showing focal global (arrowhead) and segmental (arrow) glomerulosclerosis, mesangial expansion, extensive tubulointerstitial damage, and tubular microcysts (asterisks). Rare collapsing lesions (data not shown) were also observed in this specimen but were not the predominant glomerular lesion. Homozygous Actn4 null (KO) mice aged 4 weeks (g) showing focal glomerular hypertrophy and aged 10 weeks (h) showing focal global (arrowheads) glomerulosclerosis, glomerular capillary collapse and hyalinosis, mesangial expansion, and epithelial proliferation (arrow), as well as extensive tubulointerstitial damage including tubular microcyst formation (asterisks). PAS stain. Bar=100 μm in all images. Kidney International 2008 73, 741-750DOI: (10.1038/sj.ki.5002751) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 3 Features of glomerular collapsing lesions in homozygous Actn4 transgenic mice. (a, b) Homozygous Actn4 null (KO) mouse aged 6 weeks. (a) Glomerular collapsing lesions with glomerular epithelial proliferation and no inflammation; a mitotic figure is evident among the proliferating epithelial cells in one of the glomeruli (arrow). (b) Glomerular collapsing lesion with focal accumulation of PAS-positive protein reabsorption granules in proliferating glomerular epithelial cells (arrowheads). (c, d) Homozygous Actn4 K256E mutant (KI) mouse aged 14 weeks. (c) Glomerular collapsing lesions with prominent glomerular epithelial proliferation. (d) Focally prominent PAS-positive protein reabsorption granules in epithelial cells (arrowheads) of a lesional glomerulus. PAS stain. Bar=50 μm in all images. Kidney International 2008 73, 741-750DOI: (10.1038/sj.ki.5002751) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 4 Glomerular ultrastructural abnormality scores in Actn4 transgenic mice. Mean scores for ultrastructural abnormalities in (a) glomerular basement membranes (GBM), (b) podocyte foot processes, and (c) podocyte cell bodies, scored from 0 (no abnormalities) to 4 (severe abnormalities). Data are distributed into juvenile (0–7 weeks), young adult (7–21 weeks), and old adult (>21 weeks) age groups. Genotypes indicated by WT (wild type), HET (heterozygous Actn4 K256E mutant), KI (homozygous Actn4 K256E mutant), and KO (homozygous Actn4 null). For each category of ultrastructural abnormality, height of bars indicates mean abnormality score (±s.d.) among all specimens examined within a specified genotype and age group combination. Number of specimens per age group-genotype combination (n) also indicated. *P<0.05 vs WT. Kidney International 2008 73, 741-750DOI: (10.1038/sj.ki.5002751) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 5 Glomerular ultrastructure in Actn4 transgenic mice. Representative transmitted electron photomicrographs of murine glomeruli ages 4–60 weeks. Genotypes indicated by WT (wild type), HET (heterozygous Actn4 K256E mutant), KI (homozygous Actn4 K256E mutant), and KO (homozygous Actn4 null). WT mice show no glomerular ultrastructural abnormalities at age 4 weeks (a) or 12 weeks (b); older WT mouse at age 52 weeks (c) shows mild segmental glomerular basement membrane (GBM) thickening (arrowheads). Juvenile HET mouse at 4 weeks (d) shows no glomerular ultrastructural abnormalities. Adult HET mice at 27 weeks (e) and 60 weeks (f) show segmental subepithelial GBM thickening and redundancy (arrowheads), mild podocyte foot process (FP) degenerative changes including morphologic irregularity and segmental effacement (small arrows), and mild microvillous degeneration of podocyte cell bodies (asterisks). Mild increase in cytoplasmic organelles (endolysosomes) is also noted in podocyte cell body of 60-week HET animal (f). Juvenile (g) and young adult (h) KI mice at age 4 and 12 weeks, respectively, show segmental areas of GBM redundancy (arrowheads), podocyte FP degenerative changes including FP irregularity and effacement (small arrows), and microvillous degeneration (asterisks). Changes are less prominent and segmental in 4-week KI mouse (g), and more prominent and diffuse in 12-week KI mouse (h). Prominent and irregular intracytoplasmic electron densities (large arrows) are also noted in podocyte cytoplasm of juvenile (g) and young adult (h) KI mice. Although features of podocyte injury were often apparent in young adult KI mice, specific changes characteristic of collapsing glomerulopathy were focal and are not illustrated here. Juvenile KO mouse at age 4 weeks (i) shows segmental GBM redundancy (arrowheads) and extensive podocyte FP effacement (small arrows); electron-dense protein reabsorption granules (large arrows) are also noted in glomerular epithelial cells. Young adult KO mouse at age 10 weeks (j) shows capillary collapse, GBM wrinkling and irregularity with focal redundancy (arrowheads), extensive podocyte FP effacement (small arrows), podocyte cell body hypertrophy and distortion by large vacuoles (asterisks), and electron-dense protein reabsorption granules (large arrows). Bar=2 μm in all images. Kidney International 2008 73, 741-750DOI: (10.1038/sj.ki.5002751) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 6 Composition of intracytoplasmic electron densities in homozygous Actn4 mutant (KI) mice. Immunogold transmission electron microscopy of kidney from homozygous Actn4 K256E mutant (KI) mouse at age 2 weeks showing labeling for β-actin (10 nm gold particles) and α-actinin-4 (15 nm gold particles) within intracytoplasmic electron densities. (a) Low-magnification image shows cell membrane-associated intracytoplasmic electron densities within podocyte cell body and extending into major process. High concentrations of actin and α-actinin-4 are seen within electron densities; lower concentrations of β-actin and α-actinin-4 are also observed in podocyte foot processes, and in an endothelial cell on the opposite side of the GBM at the bottom right of the image. Bar=500 nm. (b) High-magnification image confirms co-localization of both β-actin and α-actinin-4 within intracytoplasmic electron densities. Bar=200 nm. Kidney International 2008 73, 741-750DOI: (10.1038/sj.ki.5002751) Copyright © 2008 International Society of Nephrology Terms and Conditions

Figure 7 Immunohistochemical phenotype of podocytes in Actn4 transgenic mice. Immunohistochemical staining for WT-1, a marker of podocyte differentiation, reveals global nuclear staining in extracapillary cells in glomeruli of WT and HET mice, and marked absence of WT-1 staining in glomeruli of KI and KO mice that exhibit collapsing lesions (first column). Synaptopodin, another marker of podocyte differentiation, is globally positive in a peripheral capillary wall distribution in the glomeruli of WT mice, and is also globally positive but less intense in HET mice (second column). Synaptopodin staining is absent in glomeruli of KI and KO mice that exhibit collapsing lesions. Desmin, a marker of podocyte injury, is absent in glomeruli of WT and HET mice, but is segmentally positive in podocytes in lesional glomeruli of KI and KO mice (third column). Cyclin D1 (fourth column) and Ki-67 (fifth column), markers of cell cycle engagement, are negative in extracapillary glomerular cells in WT and HET mice, but show strong nuclear positivity in a subset of extracapillary cells (podocytes) of lesional glomeruli in KI and KO mice. Endocapillary cells (endothelial and/or mesangial cells) in all mice normally exhibit weak positivity for cyclin D1. Original magnification × 625 in WT and HET images and × 500 in KI and KO images. Kidney International 2008 73, 741-750DOI: (10.1038/sj.ki.5002751) Copyright © 2008 International Society of Nephrology Terms and Conditions